Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study
Launched by UNIVERSITY OF TROMSO · Dec 7, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
In Norway, there is no systematic approach for helping youth with school attendance problems. It is important to evaluate potential effective interventions and procedures for these youths. Back 2 School (B2S) is a modular cognitive behavioral intervention for youth with school attendance problems developed and evaluated through a randomized controlled trial by Professor Mikael Thastum and colleagues at the University of Aarhus, Denmark. The theoretical approach of the B2S program is trans-diagnostic, based on a modular cognitive behavior therapy (CBT) manual. The program aims at addressing ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Youth enrolled in a public school within the municipality,
- • 2. aged 6-16 years and in 1st to -10th grade (excluding second semester of the 10th grade),
- • 3. having a level of school absenteeism above 10% during the last 3 months of school (excluding legal absence, e.g., permitted extra holidays),
- • 4. The youth and at least one parent/caregiver understand and speak Norwegian sufficiently to participate in the intervention and complete questionnaires,
- • 5. At minimum one of the parents is motivated for working on increasing the youth's school attendance,
- • 6. The participating families are willing to record baseline levels of school absenteeism and to participate in assessment, intervention procedures, and follow-up assessment,
- • 7. Written informed consent from caregiver with judicial parental rights and responsibilities (usually both parents) to take part in the B2S pilot study is obtained.
- Exclusion Criteria:
- • Youth with a diagnosis of autism spectrum disorders cannot be included in the pilot study (exclusion criteria). Also, youth in need of acute and/or more intensive specialist mental health services (e.g., due to suicidal risk, ongoing symptoms of psychosis, ongoing eating disorder) cannot be included.
Trial Officials
Frode Adolfsen, PHD
Study Chair
UiT
Kristin G Askeland, PHD
Study Chair
NORCE Norwegian Research Centre AS
Simon P Neumer, PHD
Study Chair
Regionssenter for barn og unge
About University Of Tromso
The University of Tromsø, located in Norway, is an esteemed academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its cutting-edge facilities and interdisciplinary expertise to advance medical research, enhance patient care, and contribute to scientific knowledge. With a strong emphasis on ethical standards and regulatory compliance, the University of Tromsø collaborates with healthcare professionals and researchers to design and implement clinical trials that address critical health challenges, ultimately aiming to improve health outcomes and inform clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, , Norway
Oslo, , Norway
Tromsø, , Norway
Trondheim, , Norway
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials